Cutler Group’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,615
| Closed | -$38K | – | 2196 |
|
|
2023
Q1 | $38K | Sell |
1,615
-7,354
| -82% | -$173K | ﹤0.01% | 696 |
|
|
2022
Q4 | $94K | Sell |
8,969
-4,221
| -32% | -$44.2K | 0.01% | 632 |
|
|
2022
Q3 | $59K | Hold |
13,190
| – | – | ﹤0.01% | 833 |
|
|
2022
Q2 | $52K | Buy |
13,190
+800
| +6% | +$3.15K | ﹤0.01% | 877 |
|
|
2022
Q1 | $90K | Sell |
12,390
-200
| -2% | -$1.45K | ﹤0.01% | 843 |
|
|
2021
Q4 | $70K | Hold |
12,590
| – | – | ﹤0.01% | 1072 |
|
|
2021
Q3 | $80K | Buy |
12,590
+8,200
| +187% | +$52.1K | ﹤0.01% | 1046 |
|
|
2021
Q2 | $37K | Buy |
4,390
+200
| +5% | +$1.69K | ﹤0.01% | 1342 |
|
|
2021
Q1 | $43K | Buy |
4,190
+2,690
| +179% | +$27.6K | ﹤0.01% | 1224 |
|
|
2020
Q4 | $25K | Buy |
1,500
+1,100
| +275% | +$18.3K | ﹤0.01% | 1221 |
|
|
2020
Q3 | $5K | Sell |
400
-500
| -56% | -$6.25K | ﹤0.01% | 1458 |
|
|
2020
Q2 | $12K | Sell |
900
-400
| -31% | -$5.33K | ﹤0.01% | 1207 |
|
|
2020
Q1 | $11K | Buy |
+1,300
| New | +$11K | ﹤0.01% | 1117 |
|
|
2019
Q4 | – | Sell |
-3,800
| Closed | -$25K | – | 2306 |
|
|
2019
Q3 | $25K | Buy |
3,800
+3,400
| +850% | +$22.4K | ﹤0.01% | 1008 |
|
|
2019
Q2 | $4K | Buy |
+400
| New | +$4K | ﹤0.01% | 1408 |
|